Valuation dashboard for CVRx, Inc. (CVRX) with P/E N/A, P/B 3.99, EV/EBITDA -1.68 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure.
Analysis Summary
CVRx, Inc. reported revenue of $56.7M in the most recent fiscal year, growing at a 5-year CAGR of 56.4%.
Trailing-twelve-month margins: gross margin 86.6%, operating margin -79.5%, net margin -84.9%.
At the current price of $3.02, CVRX has negative trailing earnings (P/E not meaningful) and an ROE of -152.35%. Market capitalisation stands at $80M.
Balance sheet quality for CVRX: current ratio of 7.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.99 |
| EV / EBITDA | -1.68 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| CVRX | CVRx, Inc. | $80M | 3.99 | -152.4% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 28.37 | 4.41 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $65.3B | 17.84 | 2.62 | 14.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $3.02 |
| Market Cap | $80M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -152.35% |
| Return on Invested Capital | -59.64% |
| Return on Assets | -56.31% |
| Gross Margin | 86.60% |
| Operating Margin | -79.49% |
| Net Margin | -84.93% |
Related companies: CERS · MASS · NNOX · OMI · PRQR · QTRX · SENS
Explore sector: Healthcare · Medical - Devices
More sections of CVRX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks